Tetra Bio-Pharma’s has received a positive opinion from the EMA’s Committee for Orphan Medicinal Products on its application for Orphan...
Oxford Cannabinoid Technologies has signed agreements to accelerate the development of a pain management solution using phytocannabinoids.
The deal will see the companies develop new products to target specific medical conditions.
MGC Pharma has signed a Supply and Distribution Agreement with AMC Holdings.
CBD Science has announced the launch of a funding raise to help advance cannabis-based treatments for cancer pain.
Oxford Cannabinoid Technologies has signed a worldwide exclusive licence agreement with Canopy Growth Corporation.
Grow and Sanoid aim to supply high quality cannabis products at an affordable price point for patients.
MGC Pharmaceuticals has received a Free Trade Certificate in Germany for its product ArtemiC which has shown successful results in treating COVID-19 patients.
The medicine will now be available on prescription for patients in the UK.
Motagon says the import is a unique medical cannabis frontier with immense potential.
